COMMD1 and breast cancer: We were able to replicate the enhanced cisplatin sensitivity in the breast cancer cell line MDA-MB-231 upon COMMD1 silencing (S2 Fig), which would indicate that the effects of COMMD1 on cisplatin response and tumor behavior are cell-type specific.